Tvardi Therapeutics Stock Forecast

Sell candidate since Jul 22, 2026 Loss -36.23%

The Tvardi Therapeutics, Inc. stock price fell by -5.88% on the last day (Monday, 10th Aug 2026) from $1.87 to $1.76. During the last trading day the stock fluctuated 8.05% from a day low at $1.74 to a day high of $1.88. The price has fallen in 7 of the last 10 days and is down by -30.71% for this period. Volume has increased on the last day by 279 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 382 thousand shares were bought and sold for approximately $671.98 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -26.27% during the next 3 months and, with a 90% probability hold a price between $0.545 and $3.26 at the end of this 3-month period.

TVRD Signals & Forecast

There are few to no technical positive signals at the moment. The Tvardi Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.95 and $2.52. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -64.80%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Tvardi Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Tvardi Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.50. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.140 between high and low, or 8.05%. For the last week, the stock has had daily average volatility of 7.59%.

Tvardi Therapeutics, Inc. is oversold on RSI14 (5). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TVRD) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Tvardi Therapeutics, Inc. to open at $1.79, and during the day (based on 14 day Average True Range), to move between $1.61 and $1.91, which gives a possible trading interval of +/-$0.309 (+/-19.24%) up or down from last closing price. If Tvardi Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 19.24% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.85 (5.11%) than the support at $1.50 (14.77%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Tvardi Therapeutics, Inc. stock A Buy?

Tvardi Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.282 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $1.79 ( 1.89%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk